General
Preferred name
CLORAZEPIC ACID
Synonyms
clorazepate ()
CLORAZEPATE DIPOTASSIUM ()
CLORAZEPATE MONOPOTASSIUM ()
Clorazepate ()
Chlorazepate ()
4306-CB FREE ACID ()
ABBOTT-35616 FREE ACID ()
ABBOTT-39083 ()
Clorazepate potassium ()
Potassium Clorazepate ()
4311 CB ()
4311-CB ()
P&D ID
PD009881
CAS
20432-69-3
23887-31-2
5991-71-9
57109-90-7
Tags
available
drug candidate
prodrug
drug
Approved by
FDA
First approval
1972
Drug Status
illicit
approved
withdrawn
Drug indication
Anxiety disorder
Tranquilizer (minor)
Max Phase
Phase 4
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION The marketed formulation is a racemic mixture of stereo-isomers; R-clorazepate and S-clorazepate. We show the non-isomeric molecule to represent this mixture. (GtoPdb)
Compound Sets
13
ChEMBL Approved Drugs
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
DrugMatrix
Guide to Pharmacology
NCATS Inxight Approved Drugs
ReFrame library
Withdrawn 2.0
External IDs
44
Properties
(calculated by RDKit )
Molecular Weight
314.05
Hydrogen Bond Acceptors
3
Hydrogen Bond Donors
2
Rotatable Bonds
2
Ring Count
3
Aromatic Ring Count
2
cLogP
2.58
TPSA
78.76
Fraction CSP3
0.06
Chiral centers
1.0
Largest ring
7.0
QED
0.84
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
ATC
N05BA05
Toxicity type
multiple
Therapeutic Class
Hypnotics and Sedatives
Source data